Effect of dietary intervention and weight loss on circulating and hepatic expression of fibroblast growth factor-21 in non alcoholic steatohepatitis

被引：0
|
作者：
Donnini, D. [1 ]
Cappello, D. [1 ]
Carnelutti, A. [1 ]
Bonasia, V. [1 ]
Pagano, C. [2 ]
Vettor, R. [2 ]
Favaretto, F. [2 ]
Leandri, S. [2 ]
Sechi, L. [1 ]
Soardo, G. [1 ]
机构：
[1] Univ Udine, Liver Unit, Dept Pathol & Expt & Clin Med, I-33100 Udine, Italy
[2] Univ Padua, Endocrine Metab Lab, Dept Med & Surg Sci, I-35100 Padua, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2011年 / 43卷
关键词：
D O I：
10.1016/S1590-8658(11)60058-3
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S83 / S83
页数：1
相关论文
共 50 条
  • [41] Hepatic Aryl Hydrocarbon Receptor Attenuates Fibroblast Growth Factor 21 Expression
    Girer, Nathaniel G.
    Murray, Iain A.
    Omiecinski, Curtis J.
    Perdew, Gary H.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (29) : 15378 - 15387
  • [42] Circulating Fibroblast Growth Factor-21 Levels in Rheumatoid Arthritis: Associations With Disease Characteristics, Body Composition, and Physical Functioning
    Gould, Patrick W.
    Zemel, Babette S.
    Taratuta, Elena G.
    Baker, Joshua F.
    [J]. JOURNAL OF RHEUMATOLOGY, 2021, 48 (04) : 504 - 512
  • [43] Circulating Fibroblast Growth Factor-21 Levels in Rheumatoid Arthritis: Associations with Disease Characteristics, Body Composition, and Physical Functioning
    Gould, Patrick
    Zemel, Babette
    Taratuta, Elena
    Baker, Joshua
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [44] Circulating levels of fibroblast growth factor-21 increase with age independently of body composition indices among healthy individuals
    Hanks, Lynae J.
    Gutierrez, Orlando M.
    Bamman, Marcas M.
    Ashraf, Ambika
    McCormick, Kenneth L.
    Casazza, Krista
    [J]. JOURNAL OF CLINICAL AND TRANSLATIONAL ENDOCRINOLOGY, 2015, 2 (02): : 77 - 82
  • [45] NOCTURNAL INCREASE OF CIRCULATING FIBROBLAST GROWTH FACTOR 21 IS CORRELATED WITH SEVERITY OF NON-ALCOHOLIC FATTY LIVER DISEASE IN CHILDREN
    Crudele, A.
    Mosca, A.
    Corte, C. D.
    Panera, N.
    Nobili, V.
    Alisi, A.
    [J]. JOURNAL OF HEPATOLOGY, 2016, 64 : S475 - S475
  • [46] A PEGylated fibroblast growth factor 21 variant improves hepatic steatosis in a mouse model of non-alcoholic steatohepatitis, as determined by magnetic resonance imaging-derived hepatic fat-fraction
    Tang, H.
    Fronheiser, M.
    Boehm, S.
    Pena, A.
    Shorts, A.
    Zinker, B.
    Krupinski, J.
    Malone, H.
    Chow, P.
    Charles, E.
    Du, S.
    Hayes, W.
    [J]. JOURNAL OF HEPATOLOGY, 2018, 68 : S404 - S404
  • [47] Expression of Fibroblast Growth Factor-21 in Muscle Is Associated with Lipodystrophy, Insulin Resistance and Lipid Disturbances in Patients with HIV
    Lindegaard, Birgitte
    Hvid, Thine
    Grondahl, Thomas
    Frosig, Christian
    Gerstoft, Jan
    Hojman, Pernille
    Pedersen, Bente Klarlund
    [J]. PLOS ONE, 2013, 8 (03):
  • [48] Associations of Circulating Irisin and Fibroblast Growth Factor-21 Levels with Measures of Energy Homeostasis in Highly Trained Adolescent Rhythmic Gymnasts
    Jurimae, Jaak
    Remmel, Liina
    Tamm, Anna-Liisa
    Purge, Priit
    Maasalu, Katre
    Tillmann, Vallo
    [J]. JOURNAL OF CLINICAL MEDICINE, 2022, 11 (24)
  • [49] Protective effect of hepatic fibroblast growth factor 21 (FGF21) on hepatic steatosis and liver damage
    Martinez-Garza, U.
    Sandoval, V.
    Sanz, H.
    Torres, D.
    Yarritu, A.
    Haro, D.
    Marrero, P.
    [J]. ANNALS OF NUTRITION AND METABOLISM, 2019, 75 : 39 - 40
  • [50] Fibroblast growth factor signaling in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Paving the way to hepatocellular carcinoma
    Ocker, Matthias
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2020, 26 (03) : 279 - 290
12345